发明名称 |
DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE |
摘要 |
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions such as complex regional pain syndrome. |
申请公布号 |
US2017056427(A1) |
申请公布日期 |
2017.03.02 |
申请号 |
US201615352461 |
申请日期 |
2016.11.15 |
申请人 |
ANTECIP BIOVENTURES II LLC |
发明人 |
Tabuteau Herriot |
分类号 |
A61K31/675;A61K9/00 |
主分类号 |
A61K31/675 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating pain associated with complex regional pain syndrome comprising orally administering a dosage form comprising zoledronic acid in an acid form or a salt form to a human being in need thereof, wherein the bioavailability of zoledronic acid in the dosage form is about 1.5% to about 1.8%, as determined when orally administered to a human being who has fasted for eight hours. |
地址 |
New York NY US |